Malaria: Novartis develops an experimental treatment
Author: Ali BambaPublished on: November 15, 2025Country: Canada
HealthScience

Pharmaceutical company Novartis has developed GanLum, the first new class of malaria drugs in 25 years, with a cure rate exceeding 97%. This treatment has shown effectiveness against mutant parasites and was presented at a conference in Toronto.
Read original article
fr.africanews.comStay informed with NewsBoulevard
Get the latest news summaries delivered to your inbox


